Stay updated with breaking news from Volume Based Procurement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sanofi continues to deliver strong business EPS(1) growth driven by higher sales and improved margins in Q1 Paris, April 28, 2022 Q1 2022 sales growth of 8.6% at CER driven by Dupixent and CHC
AstraZeneca’s results will benefit from the acquisition of Alexion, but questions remain over its Covid-19 drugs and the outlook in China.
By the pandemic year of 2020, China accounted for the bulk of exports of certain pharmaceutical raw materials. The country now plays an indispensable role in the supply chain for antibiotics and vitamins.
Merck's women's health-focused spinoff Organon reported total net revenue came in at $6.3 billion for 2021.
Investegate announcements from Sanofi - Aventis Groupe, Press Release: Strong 2021 sales and business EPS growth enabling increased investment in R&D